.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 9,144,561

« Back to Dashboard

Claims for Patent: 9,144,561

Title:Pharmaceutical compositions having desirable bioavailability
Abstract: The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.
Inventor(s): Kabra; Bhagwati P. (Euless, TX)
Assignee: Alcon Research, Ltd. (Fort Worth, TX)
Application Number:14/267,668
Patent Claims: 1. An ophthalmic pharmaceutical composition, comprising: a pharmaceutical vehicle suitable for topical application to an eye of a human; at least 0.001 w/v % but less than 0.01 w/v % travoprost as a therapeutic agent for lowering intraocular pressure; greater than 0.0003 w/v % but less than 0.003 w/v % polymeric quaternary ammonium compound as a preservative; and an effectively low amount of surfactant sufficient for providing a high degree of bioavailability of the travoprost, wherein: i. the amount of surfactant is at least 0.01 w/v % but below 0.4 w/v % of the composition; ii. the surfactant is entirely ethoxylated and hydrogenated castor oil; iii. the composition is substantially free of benzalkonium chloride; and iv. the pharmaceutical vehicle includes water.

2. A composition as in claim 1 wherein the concentration of the surfactant is at least 0.03 w/v % but less than 0.3 w/v %.

3. A composition as in claim 1 wherein the composition has a pH of 6.4 to 7.5.

4. A composition as in claim 1 wherein the surfactant is non-ionic.

5. A composition as in claim 1 wherein the composition has a pH of 6.4 to 7.2.

6. A composition as in claim 1 wherein the composition satisfies Ph. Eur. A, Ph. Eur. B or both.

7. A composition as in claim 1 wherein the composition is disposed in an eye dropper.

8. A composition as in claim 1 wherein concentration of the surfactant in the composition is less than 0.15 w/v %.

9. A composition as in claim 1 wherein the surfactant is entirely Polyoxyl 40 Hydrogenated castor Oil.

10. A composition as in claim 1 wherein the travoprost is in the composition at a concentration of less than 0.006 w/v %.

11. A composition as in claim 1 wherein concentration of the polymeric quaternary ammonium compound in the composition is greater than 0.0007 w/v % but less than 0.0015 w/v % of the pharmaceutical composition.

12. A composition as in claim 1 wherein the polymeric quaternary ammonium compound is polyquaternium-1.

13. A composition as in claim 2 wherein the composition has a pH of 6.4 to 7.5.

14. A composition as in claim 13 wherein the travoprost is in the composition at a concentration of less than 0.006 w/v %.

15. A composition as in claim 14 wherein the surfactant is entirely Polyoxyl 40 Hydrogenated castor Oil.

16. A composition as in claim 15 wherein concentration of the polymeric quaternary ammonium compound in the composition is greater than 0.0007 w/v % but less than 0.0015 w/v % of the pharmaceutical composition.

17. A composition as in claim 16 wherein the composition is disposed in an eye dropper.

18. A composition as in claim 17 wherein concentration of the surfactant in the composition is less than 0.15 w/v %.

19. A composition as in claim 18 wherein the composition satisfies Ph. Eur. A, Ph. Eur. B or both.

20. A composition as in claim 19 wherein the composition has a pH of 6.4 to 7.2.

21. A composition as in claim 20 wherein the surfactant is non-ionic.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc